Outset Medical (OM) Return on Capital Employed (2020 - 2026)
Outset Medical (OM) reported Return on Capital Employed of 30.65% for Q1 2026, up 587.0% year-over-year from 4.46% in Q1 2025, and down 7.15% quarter-over-quarter from 28.6% in Q4 2025.
Outset Medical (OM) Return on Capital Employed (2020 - 2026) Analysis & Trends
Outset Medical (OM) has 7 years of Return on Capital Employed data on file, last reported at 30.65% in Q1 2026.
- Return on Capital Employed for Q1 2026 came in at 30.65%, up 587.0% year-over-year; the trailing twelve-month figure through Mar 2026 was 30.65% (up 587.0% YoY), and the FY2025 annual result was 28.69%, up 1677.0% from the prior year.
- Return on Capital Employed declined to 30.65% in Q1 2026 per OM's latest filing, from 28.6% in the prior quarter.
- Over five years, Return on Capital Employed peaked at 28.6% in Q4 2025 and troughed at 66.48% in Q4 2023.
- A 5-year average of 45.46% and a median of 48.53% in 2022 frame the typical range for Return on Capital Employed.
- The sharpest annual moves came in 2022 and 2025: Return on Capital Employed tumbled 2188 bps in 2022, then surged 2190 bps in 2025.
- A 5-year view of Return on Capital Employed shows it stood at 48.65% in 2022, then tumbled by 37 bps to 66.48% in 2023, then gained by 29 bps to 47.44% in 2024, then surged by 40 bps to 28.6% in 2025, then dropped by 7 bps to 30.65% in 2026.
- Business Quant data shows OM's Return on Capital Employed at 30.65% in Q1 2026, 28.6% in Q4 2025, and 28.89% in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROCE (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.92 Bn | 146.27 Bn | 6.27 Bn | 9.61% |
| 2 | Stryker | 119.50 Bn | 116.62 Bn | 3.81 Bn | 12.24% |
| 3 | Medtronic | 102.71 Bn | 94.54 Bn | 5.76 Bn | 7.36% |
| 4 | Boston Scientific | 69.72 Bn | 68.51 Bn | 3.61 Bn | 9.62% |
| 5 | Edwards Lifesciences | 49.24 Bn | 45.57 Bn | 1.29 Bn | 11.13% |
| 6 | GE HealthCare Technologies | 29.74 Bn | 27.67 Bn | 1.98 Bn | 9.30% |
| 7 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | 10.45% |
| 8 | Dexcom | 28.96 Bn | 27.84 Bn | 750.30 Mn | 24.24% |
| 9 | Steris | 20.31 Bn | 19.88 Bn | 697.10 Mn | 11.57% |
| 10 | Outset Medical | 81,759.85 | -286.56 Mn | 12.10 Mn | -30.65% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -30.65% |
| Dec 31, 2025 | -28.60% |
| Sep 30, 2025 | -28.89% |
| Jun 30, 2025 | -30.59% |
| Mar 31, 2025 | -36.52% |
| Dec 31, 2024 | -47.44% |
| Sep 30, 2024 | -49.32% |
| Jun 30, 2024 | -52.44% |
| Mar 31, 2024 | -58.42% |
| Dec 31, 2023 | -66.48% |
| Sep 30, 2023 | -64.28% |
| Jun 30, 2023 | -55.98% |
| Mar 31, 2023 | -49.84% |
| Dec 31, 2022 | -48.65% |
| Sep 30, 2022 | -48.53% |
| Jun 30, 2022 | -41.84% |
| Mar 31, 2022 | -34.44% |
| Dec 31, 2021 | -30.75% |
| Sep 30, 2021 | -26.64% |
| Jun 30, 2021 | -32.42% |